HCPLive

Fred Poordad, MD, on Ethnic Differences in Telaprevir Treatment Effect

$shareThis$
In this video Fred Poordad, MD, Chief of Hepatology and Liver Transplantation at the Comprehensive Transplant Center at Cedars-Sinai Medical Center evaluates the effect of race on the response to treatment and viral resistance profiles with telaprevir combination therapy.

 

Most Popular

Recommended Reading

While supplemental feeding of wildlife may seem beneficial for animals, a new study suggests that it has the potential to increase the spread of infectious diseases to humans.
The recent measles outbreak linked to an amusement park in southern California had reignited a controversy about the values of public health, personal choice, and parental rights.
Nearly a million children annually develop tuberculosis (TB), with caseloads highly concentrated in areas affected by poverty and social disruption.
America is making slow but steady progress against cancer, with a continuing decline in cancer deaths, according to a new report published online March 30 in the Journal of the National Cancer Institute. The report was coauthored by experts from the North American Association of Central Cancer Registries, the American Cancer Society, the U.S. Centers for Disease Control and Prevention, and the U.S. National Cancer Institute.

$vacMongoViewPlus$ $vAR$